Corporate Venture Capital Firms

Accenture Ventures is the corporate venture capital arm of Accenture plc, a global professional services company. Established in 2015, the firm focuses on making strategic investments in early- and growth-stage technology companies. Its primary objective is to identify and partner with startups developing innovative enterprise and industry-focused technologies, integrating their capabilities into Accenture's extensive services and client solutions. This approach emphasizes strategic impact and accelerating product-market fit for its portfolio companies, leveraging Accenture's vast global client base and deep industry expertise.The firm's investment thesis centers on technologies that drive digital transformation and enhance enterprise capabilities. Key areas of focus include artificial intelligence (AI), cloud computing, cybersecurity, blockchain, data and analytics, and digital engineering. Accenture Ventures actively seeks out companies that can provide vertical AI solutions tailored to specific sectors such as financial services, healthcare, manufacturing, retail, and the public sector. They also explore emerging trends like physical AI and robotics, aiming to bridge the gap between groundbreaking ideas and scalable enterprise solutions.Accenture Ventures manages a $250 million fund and has made over 70 active venture investments. Notable portfolio companies include Replit, a platform for developing and deploying applications with AI; Sanctuary AI, a developer of AI-powered general-purpose robots; Open Cosmos, an operator of space missions providing satellite data; and Pixxel, which offers hyperspectral imaging satellites. The firm typically invests in Series A and Series B rounds, supporting startups through various stages of growth.The team at Accenture Ventures includes experienced professionals such as Tom Lounibos, Avnish Sabharwal, and Joe Lui. They bring a wealth of knowledge in technology and venture capital, working closely with portfolio companies to provide not just capital, but also strategic guidance, market access to Fortune Global 500 clients, and opportunities for co-innovation. The firm's global mandate allows it to invest across continents, emphasizing execution and local market understanding to support diverse innovation hubs.

AMD Ventures is the corporate venture capital arm of Advanced Micro Devices (AMD), headquartered in Santa Clara, California. As a global, multi‑stage investor, it partners with startups aligned to AMD’s vision of pervasive AI, next‑generation data‑center technologies, GPU/cloud infrastructure, silicon photonics, and emerging compute architectures. With AMD’s technical expertise, marketing reach, and ecosystem support, it aims to accelerate innovation across hardware and software domains. The fund invests in startups across horizontal and vertical AI platforms spanning life sciences, financial services, gaming, data center infrastructure, and core chip technologies including cooling and advanced packaging. Notable investments include Ayar Labs, Liquid AI, TensorWave, Cohere, Hugging Face, Luma AI, Celestial AI, Seekr, xAI, Vultr, and more—demonstrating strong activity especially throughout 2025. By selecting AMD Ventures, portfolio companies gain access to AMD’s deep technical talent pool, participation in marketing and PR programs, collaboration with ecosystem partners, and a long‑term commitment from a strategic corporate investor who “thinks in years, not months.

American Family Ventures is the corporate venture capital arm of American Family Insurance, established in 2010 to invest in the future of the insurance industry. The firm operates across the full investment spectrum from incubation through growth stage, focusing on innovations that transform insurance product lines, adjacent vertical markets, and enabling technologies. With over $700 million in assets under management and limited partners representing $70 billion in premium, AFV has evolved from a single-LP model into a multi-limited partner institutional firm that brings both carrier expertise and venture capital perspective to its portfolio companies.Founded in 2010 as an internal innovation arm of American Family Insurance, AFV emerged from the recognition that insurance was undergoing profound transformation. The firm was designed to capitalize on this moment by positioning itself as a venture partner of choice, uniquely bridging the gap between established insurance carriers and innovative startups. Over its 16-year history, the firm has developed deep expertise combining 50+ years of venture capital experience with 120+ years of insurance industry knowledge across its team, allowing it to review over 1,500 companies annually and identify the most promising opportunities.AFV's portfolio encompasses more than 100 active investments spanning core insurance innovations, adjacent vertical markets, and enabling technologies. Notable portfolio companies include Clearcover, a digital-first auto insurance company; Elysian, which transforms claims processing with computer vision and AI; Wyze, a smart home IoT company; Venteur, which helps employers offer personalized health benefits; LeaseLock, providing lease insurance; and Turtlemint, a mobile platform for insurance agents. The firm has also achieved successful exits, including the acquisition of Networked Insights by American Family Insurance in 2017, Life360's IPO on the Australian Stock Exchange in 2019, and Neat Capital's acquisition by Lower.com in 2024.The firm maintains offices in Boston, Madison, Minneapolis, New York, and Philadelphia, with a team led by Head of American Family Ventures Eyal Karsh and supported by experienced investment professionals including managing directors, principals, and portfolio managers. AFV's investment approach typically involves first checks ranging from $250,000 to $10 million, with the firm providing not only capital but also strategic guidance, industry connections, and operational expertise drawn from its parent company's extensive insurance background. The firm's advisory network and platform services further support portfolio companies in navigating the complex insurance landscape and scaling their operations.

Angelini Ventures is a prominent investment firm focused on the health technology and drug discovery sectors. With a strategic approach to venture capital, the firm aims to support innovative companies that are poised to make significant impacts in healthcare. Angelini Ventures is particularly interested in businesses that are developing cutting-edge technologies and solutions that enhance patient care and improve clinical outcomes. Angelini Ventures employs a rigorous investment strategy that emphasizes the importance of clinical validation and market demand. The firm targets companies that are at the intersection of hardware and software, particularly those that can leverage data analytics to enhance diagnostic capabilities. This focus is driven by the increasing need for non-invasive monitoring solutions in critical care settings, where traditional methods can be invasive and costly. Angelini Ventures is committed to fostering innovation in various sectors, including: Medtech: Investing in companies that develop medical devices and technologies that improve patient outcomes. Pharmaceuticals: Supporting drug discovery and development initiatives that address unmet medical needs. Digital Health: Focusing on solutions that enhance healthcare delivery through technology and data integration. Angelini Ventures has a clear vision of transforming healthcare through strategic investments that align with its core values of patient impact and system-level improvements. The firm recognizes the growing demand for advanced neuro-monitoring solutions as hospitals strive to reduce avoidable neurological complications and improve patient care efficiency. As the healthcare landscape continues to evolve, Angelini Ventures remains committed to identifying and supporting innovative companies that are poised to lead the charge in health technology. The firm’s strategic investments not only provide financial backing but also offer valuable insights and resources to help portfolio companies navigate the complexities of regulatory pathways and market entry. With a focus on delivering high-margin devices coupled with subscription or analytics services, Angelini Ventures is well-positioned to capitalize on the growing intersection of medtech and software-enabled diagnostics. The firm’s ability to provide continuous streams of validated physiological data opens up new licensing opportunities and partnerships within the healthcare ecosystem.

Bosch Ventures, officially known as Robert Bosch Venture Capital GmbH (RBVC), is the corporate venture capital arm of the Bosch Group. Established in 2007, RBVC invests globally in innovative startups across all stages of development, focusing on technologies that are strategically significant to Bosch's future. RBVC's investment portfolio encompasses sectors such as automation, electrification, energy efficiency, enabling technologies, and healthcare systems. By leveraging Bosch's extensive global network and industry expertise, RBVC provides not only capital but also strategic support to its portfolio companies, fostering growth and innovation. With offices in Germany, the United States, Israel, and China, RBVC maintains a strong international presence. The firm typically invests between €500,000 and €10 million per company, with total assets under management exceeding €200 million.

Capital One Ventures is the corporate venture capital arm of Capital One Financial Corporation, established in 2014. Headquartered in McLean, Virginia, with additional offices in San Francisco and New York, the firm focuses on strategic investments that align with Capital One's mission to drive innovation in financial services. By investing in pioneering startups, Capital One Ventures aims to accelerate technological advancements and enhance customer experiences. The firm targets early to growth-stage companies operating in sectors such as fintech, artificial intelligence, data analytics, cybersecurity, and enterprise software. Capital One Ventures provides not only capital but also strategic support, leveraging Capital One's extensive resources and industry expertise to help portfolio companies scale and succeed. Notable investments include Snowflake, Databricks, and Eightfold. With a portfolio of over 120 companies and a track record of successful exits, Capital One Ventures continues to play a pivotal role in shaping the future of financial services. The firm's collaborative approach and commitment to innovation position it as a key player in the venture capital landscape.

Citi Ventures is the corporate venture capital arm of Citigroup, established in 2008 to drive innovation and strategic growth across the financial services ecosystem. Headquartered in Palo Alto, California, the firm operates globally with offices in New York, San Francisco, London, Singapore, and Tel Aviv. Citi Ventures focuses on investing in startups that align with Citi's mission to enable growth and economic progress. The firm targets early to growth-stage companies operating in sectors such as financial technology, data analytics, artificial intelligence, commerce and payments, security and enterprise IT, and customer experience. By leveraging Citi's global network and resources, Citi Ventures provides portfolio companies with unparalleled access to markets, clients, and industry expertise. With a portfolio of over 200 companies and a track record of more than 30 successful exits, Citi Ventures plays a pivotal role in shaping the future of financial services. The firm's collaborative approach and commitment to innovation position it as a key player in the venture capital landscape.

Dell Technologies Capital (DTC) is the global venture capital arm of Dell Technologies, established in 2012. Headquartered in Palo Alto, with offices also in Boston and Tel Aviv, DTC has invested more than USD 1.7 billion in early-stage enterprise technology companies across the U.S., Europe, and Israel. Nine investments have led to public offerings, and over 85 portfolio companies have been acquired by tech leaders including Amazon, Apple, Cisco, Intel, Microsoft, VMware and Dell itself. DTC typically takes the lead in Seed and Series A funding rounds, taking board seats and offering more than capital. Their support includes customer introductions, market-fit coaching, pricing guidance, sales leadership mentoring, media support, and pipeline benchmarking. While backed by Dell Technologies, DTC operates as a financial returns-driven VC with performance consistently in the 95th percentile of early-stage investors. The firm targets transformative enterprise and infrastructure technologies—particularly in cybersecurity, artificial intelligence and machine learning, data analytics, edge and logistics, developer tools, silicon, and IoT. The team seeks technical founders with deep domain expertise and customer empathy who are building category-defining solutions. DTC remains actively deploying capital and leading rounds across its core geographies.

Founded in 2019 and headquartered in Munich, Germany, Hitachi Ventures is the global corporate venture capital (CVC) arm of Hitachi Group. Operating as a standalone, return‑driven fund with Hitachi as its sole limited partner, the firm focuses on building partnerships with visionary founders to drive breakthrough innovation across climate, health, digital and industrial sectors. With offices in Munich, Boston and Palo Alto, Hitachi Ventures invests globally in startups aligned with Hitachi’s mission of social innovation. Under the leadership of CEO & Managing Director Dr. Stefan Gabriel—who founded the CVC and brings over 20 years of venture and corporate innovation experience—the firm invests in early to mid‑stage startups (primarily pre‑seed to Series B/C). Hitachi Ventures provides both capital and strategic alignment with Hitachi’s business units, enabling collaboration and scale opportunities across industry, digital, environment and healthcare domains. The firm currently manages four funds, including Fund IV launched in February 2025 with a commitment of $400 million, bringing total assets under management to approximately $1 billion. Hitachi Ventures seeks startups primarily in Europe, Israel and North America, targeting areas like Industry 5.0, TechBio, AI/data infrastructure, circular economy solutions, decarbonization and frontier deep‑tech.

Intel Capital, established in 1991 as the investment arm of Intel Corporation, is a pioneering corporate venture capital firm dedicated to advancing the future of computing. Over three decades, it has invested more than $20 billion in over 1,800 companies worldwide, focusing on strategic equity investments that support Intel’s ecosystem and foster innovation across multiple technology domains. Intel Capital spun off as a standalone investment fund, continuing its mission with greater independence while maintaining strong ties to Intel.The firm invests primarily in early-stage startups and growth companies across four key areas of the technology ecosystem: Cloud, Devices, Frontier (including quantum computing and AI), and Silicon. Intel Capital leverages Intel’s resources by placing over 200 Embedded Experts within portfolio companies and facilitating more than 1,300 curated introductions to Global 2000 customers annually, helping startups scale and succeed in competitive markets.Intel Capital’s portfolio includes notable investments in artificial intelligence, autonomous technology, semiconductor manufacturing, cybersecurity, and next-generation compute infrastructure. The firm has a strong track record with over 700 portfolio exits and has created over $170 billion in market value in the last decade. Its global investment footprint spans North America, Western Europe, Israel, and Asia Pacific, reflecting a comprehensive approach to fostering innovation worldwide.

Koch Disruptive Technologies (KDT) is the venture capital arm of Koch, Inc., founded in November 2017 and led by Chase Koch. With an ethos rooted in “creative destruction,” KDT partners with principled entrepreneurs building transformative platforms that can both elevate Koch’s core capabilities and open entirely new industrial frontiers. KDT invests across a wide spectrum of high-growth sectors including healthcare, supply-chain & manufacturing, cybersecurity, fintech, semiconductors, connectivity, enterprise software, and energy transformation. It leverages internal resources through its Koch Labs network, offering portfolio companies access to Koch’s global expertise in logistics, IT, manufacturing, and more, creating mutual benefit and accelerating growth. The firm has committed over US $4 billion to disruptive enterprise-technology ventures, and maintains a strategic focus on long-term partnerships that benefit both entrepreneurs and Koch’s ecosystem. Recent lead investments include Insightec’s $150 million Series E in medical technology and Optimal Dynamics’ $40 million Series C in AI-driven logistics software.

Labcorp Venture Fund is the strategic investment arm of Labcorp, a global life sciences and diagnostics company. The fund is dedicated to supporting innovative startups in the healthcare and biotechnology sectors that align with Labcorp’s mission to improve health and improve lives. By investing in early-stage companies, the fund helps foster breakthroughs in diagnostics, drug development, digital health, and personalized medicine. The Labcorp Venture Fund provides both financial backing and strategic resources, including access to Labcorp’s extensive R&D capabilities, clinical trial infrastructure, and commercial channels. This strategic alignment allows portfolio companies to scale effectively and accelerate the impact of their solutions in the healthcare market. The fund targets investments that complement Labcorp’s core services while also exploring emerging opportunities in health technology and therapeutics. With a selective and collaborative investment approach, the Labcorp Venture Fund plays a critical role in advancing innovation across the healthcare value chain.

Lam Capital is the corporate venture capital investment arm of Lam Research Corporation, a global leader in wafer fabrication equipment and semiconductor manufacturing solutions. The firm invests in innovative companies addressing today's most challenging, high-impact problems across the semiconductor ecosystem, artificial intelligence, and industrial automation sectors. By combining financial investment with operational expertise and access to Lam Research's extensive technology network and supply chain infrastructure, Lam Capital serves as a strategic partner that goes beyond traditional venture funding to accelerate startup growth and commercialization.The firm's investment strategy is uniquely positioned at the intersection of corporate strategy and venture capital, focusing on companies that extend Lam Research's core technologies into new markets and synergistic technologies that solve complex challenges across multiple disciplines. Lam Capital invests across all stages from seed through early Series B, with a particular emphasis on hardware-related startups in semiconductor equipment, digital manufacturing, and related industries. The firm has made 18 investments as of April 2025, with a track record of 3 portfolio exits, including the notable exit of Reno Sub-Systems in March 2022.Beyond capital deployment, Lam Capital provides substantial value-add services including technical expertise from Lam Research's diverse pool of technology experts, operational guidance on scaling to high-volume manufacturing, potential customer relationships, and co-development opportunities. The firm's strategic approach integrates financial rigor with close collaboration with Lam Research's internal business units to maximize startup success and ensure strategic alignment that improves the likelihood of successful collaboration, integration, and eventual commercial deployment of portfolio company technologies.

LG Technology Ventures is the corporate venture capital (CVC) arm of LG Group, established in 2018 and headquartered in Silicon Valley, California. The firm specializes in identifying and investing in innovative startups at the forefront of technology, with a strategic focus on sectors such as artificial intelligence, biotechnology, cleantech, advanced materials, and mobility. By leveraging the global resources and expertise of LG Group, LG Technology Ventures provides not only capital but also access to strategic partnerships, industry knowledge, and operational support for its portfolio companies. The firm partners with early- and growth-stage companies worldwide, aiming to drive innovation and create value for both startups and LG affiliates. LG Technology Ventures has built a robust portfolio of over 80 active investments and has facilitated more than 10 exits or IPOs. Its investments span a wide range of industries, including AI, biotech, energy, batteries, healthcare, and advanced materials. Notable portfolio companies include Anthropic, Arcellx, Inworld AI, Figure AI, and OTI Lumionics. The team consists of experienced investors, entrepreneurs, technologists, and industry experts who work closely with founders to help them scale and succeed. LG Technology Ventures is committed to fostering long-term relationships with its portfolio companies, offering strategic guidance, access to LG’s global network, and support in navigating complex market dynamics. The firm’s approach emphasizes founder-centricity, aiming to help startups overcome challenges in talent acquisition, sales strategy, and organizational development. With a strong track record of successful investments and exits, LG Technology Ventures continues to play a pivotal role in shaping the future of technology and innovation.

M12 is the corporate venture arm of Microsoft, focused on empowering early-stage companies to scale with the backing of one of the world’s leading technology firms. Founded in 2016, M12 strategically invests in enterprise startups that align with Microsoft’s mission to enable digital transformation across industries. With a keen interest in cloud infrastructure, artificial intelligence, and cybersecurity, M12 partners with visionary founders who are building the next generation of enterprise technologies. Beyond capital, M12 provides portfolio companies with unmatched access to Microsoft’s vast technical resources, global customer network, and go-to-market support. The fund operates with a founder-first approach, emphasizing strategic guidance, industry mentorship, and long-term collaboration. Through this approach, M12 enhances the growth trajectory of its investments and fosters innovation at the edge of enterprise advancement. Headquartered in San Francisco with offices in Seattle, London, and Tel Aviv, M12 maintains a global footprint. This enables the firm to identify high-potential startups in key innovation hubs and help them scale internationally. As a sector-agnostic investor with a technology-first lens, M12 continues to play a significant role in shaping the enterprise ecosystem of the future.

Prebys Ventures is the venture capital arm of the Conrad Prebys Foundation, established to drive innovation and economic growth within the San Diego region. Launched in 2025 with a $50 million fund, it focuses on investing in early and growth-stage technology and healthcare companies based in San Diego. The fund aims to address a critical resource gap in the local innovation ecosystem by partnering with leading venture firms and leveraging a robust network of domain experts and exited CEOs. The fund operates with a unique financial model that reinvests returns back into the San Diego economy to create a sustainable, perpetually growing investment vehicle. Prebys Ventures seeks to support companies with a venture-capital growth model, typically investing between $500,000 and $2 million per round, and often taking board observer seats to actively support portfolio companies through strategic guidance and network access. Prebys Ventures is led by Managing Director Mike Krenn, a seasoned San Diego innovation community leader with a track record of raising over $800 million for regional startups. The fund’s mission is to fuel lasting economic opportunity and a thriving San Diego community by investing in companies that align with the foundation’s focus on health, research, and innovation, thereby strengthening San Diego’s position as a global innovation hub.

Samsung Catalyst Fund is the evergreen, multi‑stage corporate venture capital arm of Samsung Electronics, headquartered in San Jose, California, with offices also in Seoul, Tel Aviv and Paris. Fully owned by Samsung Electronics, it operates with independent investment decision‑making authority and fiduciary responsibility to its portfolio companies while leveraging Samsung’s global scale and domain expertise. Founded in 2013, SCF targets startups across deep‑tech infrastructure and data‑enabled platforms, spanning sectors such as data center and cloud computing, artificial intelligence, networking & 5G, automotive, sensors, quantum computing, robotics, digital health, IoT, and semiconductors. SCF pursues multi‑stage investments—from Series A to late stage—and supports portfolio companies with capital, engineering mentorship, corporate development and access to Samsung’s global resources. The fund prioritizes not just financial return but co‑prosperity: success for SCF goes hand in hand with growth for entrepreneurs, partner investors, customers, and the wider community. Its investment portfolio includes firms like Axelera AI, Axiado, Celestial AI, DreamBig Semiconductor, Groq, Enfabrica, Skylo and Tenstorrent, among others. Recent investments were made into Skylo, Axiado, Tenstorrent, Enfabrica, DreamBig, Axelera AI, and Celestial AI.

Samsung Next is the venture capital and innovation arm of Samsung Group, established to identify and invest in early-stage technology startups with disruptive potential. Founded in 2012, Samsung Next combines product development, investment, mergers & acquisitions, and strategic partnerships to drive innovation and complement Samsung’s global hardware footprint. The organization is headquartered in Mountain View, California, with additional offices in Korea, Europe, and Israel, supporting a global portfolio of startups. Samsung Next focuses on bold and ambitious founders who are reimagining foundational infrastructure and creating new consumer experiences. The firm invests across a broad spectrum of technology sectors, including artificial intelligence, blockchain, fintech, healthtech, infrastructure, and media technology. In addition to capital, Samsung Next provides startups with mentorship, access to Samsung’s global network of engineers, designers, and business experts, and resources through specialized programs such as the Samsung NEXT Stack Zero Grant and the Samsung NEXT Q Fund for quantum computing startups. The company’s investment philosophy centers on supporting transformative innovations that unlock human potential and deliver rich consumer experiences. Samsung Next is committed to empowering startups that are pushing the boundaries of what is possible, from AI-powered devices and decentralized networks to digital health platforms and next-generation consumer services. The team is fully dedicated to the growth and success of every portfolio company, fostering a collaborative ecosystem that accelerates technological advancement and market impact.

Sanofi Ventures is the corporate venture capital arm of Sanofi, one of the world’s leading healthcare companies. The firm invests in early- to mid-stage biotech, digital health, and life sciences companies with innovative platforms and technologies that align with Sanofi’s core areas of interest. Sanofi Ventures provides strategic capital to entrepreneurs and companies transforming patient care through science and innovation. Founded in 2016, Sanofi Ventures builds long-term partnerships with companies pioneering advancements in immunology, oncology, rare diseases, vaccines, and digital health. While financially driven, the firm operates with a strategic lens, supporting companies that complement Sanofi’s internal R&D and therapeutic goals. The investment team brings deep expertise in science, operations, and company-building. Operating globally from offices in the U.S. and Europe, Sanofi Ventures backs visionary teams with the potential to create significant breakthroughs in healthcare. The firm typically participates in Seed, Series A, and Series B rounds, offering both capital and access to Sanofi’s global network, infrastructure, and expertise. With a collaborative approach, Sanofi Ventures helps portfolio companies navigate growth from concept to clinic.

Shanda Group is a privately-owned multinational investment firm established in 1999 by Tianqiao Chen and Chrissy Luo. Originally founded as Shanda Interactive Entertainment, a pioneering online gaming company in China, it has evolved into a diversified investment group with a global presence. The firm operates offices in Shanghai, Singapore, Hong Kong, New York, Menlo Park, and Redwood City, focusing on investments in public markets, venture capital, private equity, and real estate. Shanda's investment strategy targets disruptive, human-oriented deep technologies, including gene-editing, robotics, anti-aging, brain-related neuroscience, and artificial intelligence. The firm has invested in over 75 early-stage venture capital funds and directly in numerous startups worldwide. Its real estate portfolio includes developments in China and significant timberland holdings in North America. Additionally, Shanda emphasizes social responsibility and philanthropy through the Tianqiao and Chrissy Chen Institute, which focuses on brain science research. With approximately $8 billion in assets under management, Shanda combines entrepreneurial vision with rigorous investment acumen. The firm’s diversified portfolio spans healthcare, financial services, media, technology, and real estate sectors, with a geographic focus on North America, China, Singapore, Hong Kong, and other global markets. Shanda continues to innovate by investing in early-stage deep tech ventures and undervalued public companies with turnaround potential.